CYP vs IDX

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

CYP

CYNATA THR FPO [CYP]

47LOW

IDX

INTEG DIAG FPO [IDX]

47LOW

Score Breakdown

CYP IDX
Technical
49
63
Catalyst
50
50
Sentiment
50
50
Fundamental
35
91
Momentum
67
72
Risk Gate
42
34

Key Metrics

CYP Metric IDX
$66.5MMarket Cap$872.6M
191KAvg Volume (20d)1.1M
N/AShort Interest+2.8%
$0.43552-Week High$3.070
$0.14052-Week Low$2.110
-1.8%Daily Change+0.4%
$0.275Entry Price$2.370
-113.0%ROE+2.1%
N/AProfit Margin+1.8%

Active Signals

CYP Signals

●RSI drifting toward oversold territory — worth watching
●Stochastic is deep in oversold territory — bounce conditions forming
●Trading below both moving averages — the trend is working against this one
●Volume surging at 2.2x normal while price falls — heavy selling pressure
●Drifting lower — down 5.2% over the last 5 days
●Trading above the 200-day average — the long-term trend is on your side
●Critical cash runway (1.3 quarters)
●4C filed 2026-01-28

IDX Signals

●Volume surging at 2.0x normal while price climbs — real buying conviction behind this move
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (1.1x)
●Strong revenue growth (+56%)
●EPS estimates revised upward (+10pts)

Ask Scout AI to compare CYP and IDX in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
CYP Full Analysis → IDX Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).